(+)-Tranylcypromine Hydrochloride


Product Details

CAT No.# CS-O-05786
Category Impurities
CAS 4548-34-9
Molecular Weight 169.65
Molecular Formula C9H1ClN
Stock Status: In-Stock
Purity: >98%
Synonyms: (+)-Tranylcypromine Hydrochloride;(+/-)-trans-2-phenn, [;AJ-26319;trans-(1r,2s)-phenycclopropyl-1-amine;FT-0693819;trans-(1r,2s)-2-phenycclopropyl-1-amine;trans-2-phenylcclopropylamine.hydrchloride;(+/-)-trans-2-phenycclopropylaminesulphate;(1r,2s)-2-phenycclopropylamine hydrchloride;(1r-trans)-2-phenycclopropanamine, [r-(r*,r*)]-2,3-dihydroxybutanedioate.
Application Notes: Antidepressive Agents; Monoamine Oxidase Inhibitors; Anti-Anxiety Agents
References: Zhang, W., et al.: Drug Metab. Dispos., 29, 897 (2001); Hong S., et al.: J. Biol.chem., 255, 9538 (1980); Taavitsainen, P., et al.: Drug Metab. Dispos., 29, 217 (2001); Negishi, T., et al.: Environ. Health Perspct., 112, 1159 (2004)
Storage: Keep in a tightly closed vial, store in refrigerator
COA / MSDS:    View COA    MSDS    Enquire
The balance used are calibrated with weights traceable to National Standards NIST for accuracy
PEOPLE ALSO SEARCHED FOR: 1. (6R,7S)-7-(2-chloroacetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
2. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
3. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
4. Benidipine D7
5. Lauroside D
6. Triazolam 13C D3
7. Icatibant impurity 1
9. 0.1% TFA in Water ULC-MS
10. Metamizole EP Impurity C HCl
11. Silodosin Metabolite D4
12. Brivaracetam Carboxylic acid metabolite [UCB 42145]
13. Terbuthylazine D5
14. tibolone (848)
15. (Z)-Dimethylvinphos
16. Silodosin Metabolite
17. 2-Phenoxymethanesulfonanilide
18. Nimesulide EP Impurity A
19. Acetone HPLC
20. Nandrolone Decanoate EP impurity F


This page contains information about (+)-Tranylcypromine Hydrochloride Cas 4548-34-9 and its Impurities.
"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."